ICRAPAIN 2025: A Global Milestone
ICRAPAIN 2025: A Global Milestone in Pain Medicine Hosted by Daradia, Kolkata
ICRAPAIN 2025, the International Conference on Recent Advances in Pain, concluded successfully in Kolkata from August 30 to September 1, 2025. Organized by Daradia: The Pain Clinic, this three-day international event brought together more than 250 participants and faculty from India, Bangladesh, Nepal, Ireland, and Malaysia. The conference highlighted the latest innovations in interventional pain management, musculoskeletal ultrasound (MSK USG), cancer pain care, and regenerative therapies, while also strengthening global collaboration in pain medicine.
Why ICRAPAIN Matters
Pain medicine is rapidly advancing, with new techniques such as ultrasound-guided interventions, minimally invasive spine procedures, and regenerative treatments changing clinical practice worldwide. However, pain remains a major global health challenge—affecting productivity, quality of life, and mental health.
ICRAPAIN was conceived by Daradia to provide a platform where:
- Physicians could learn evidence-based interventions,
- Researchers could share cutting-edge studies, and
- Young doctors could gain hands-on training to enhance their clinical skills.
Each year, the conference serves as a hub for learning, innovation, and collaboration, strengthening Daradia’s mission to integrate patient care, physician training, and research.
Highlights of ICRAPAIN 2025
The program for ICRAPAIN 2025 was meticulously designed to cover the breadth of pain medicine.
1. Interventional Spine Procedures
Delegates learned about fluoroscopy- and ultrasound-guided interventions for lumbar radicular pain, cervical interventions, radiofrequency ablation (RFA), and sympathetic blocks.
2. Musculoskeletal Ultrasound (MSK USG)
Hands-on workshops on shoulder, knee, and peripheral nerve scanning provided participants with direct exposure to diagnostic and therapeutic applications of ultrasound.
3. Cancer Pain & Palliative Care
Faculty emphasized multidisciplinary strategies for patients with advanced disease, showcasing how interventional techniques complement pharmacological treatments.
4. Regenerative Therapies
Debates on platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and biologics offered practical insights into the role of regenerative medicine in musculoskeletal pain.
5. Osteoporosis & Spine Fractures
Sessions on vertebroplasty and newer approaches to osteoporosis-related fractures were especially well received, given the rising burden of aging populations.
More Than Lectures: Interactive Learning
ICRAPAIN 2025 stood out for its emphasis on practical and interactive learning.
- Hands-on workshops gave delegates real procedural experience under expert supervision.
- Live demonstrations bridged theory with practice.
- Scientific paper presentations encouraged academic contributions from young physicians.
- Knowledge-based quiz competitions added an engaging, competitive spirit.
This blend of rigorous science and active participation kept the atmosphere lively and intellectually stimulating throughout the conference.
Leadership Voices
The success of ICRAPAIN 2025 was reflected in the words of its leaders:
Dr. Gautam Das, Founder and Director of Daradia, shared:
“When we started Daradia, our dream was to integrate clinical excellence with academic leadership. ICRAPAIN is a continuation of that mission. With over 250 delegates and international faculty this year, we have demonstrated that Kolkata can be a global hub for academic advancement in pain medicine.”
Dr. Sushpa Das, Chief Consultant at Daradia and Organizing Secretary of ICRAPAIN 2025, added:
“Pain medicine thrives on knowledge-sharing across borders. By hosting faculty from Ireland, Malaysia, Nepal, and Bangladesh alongside India’s experts, ICRAPAIN created a true platform for collaboration. The enthusiasm of delegates motivates us to keep raising the bar.”
Dr. Shirish P. Amatya, Scientific Chair of ICRAPAIN 2025, emphasized the academic vision:
“Our scientific program was designed to balance evidence-based practice with practical skills and emerging therapies. The delegates’ engagement proved that this approach created real value.”
Dr. Smrutirekha Hota, Scientific Secretary of ICRAPAIN 2025, highlighted inclusivity:
“The success of ICRAPAIN lay in its diversity—young researchers presenting papers, senior faculty demonstrating interventions, and delegates learning hands-on. Every session added something meaningful.”
Daradia’s Global Role in Pain Medicine
Daradia: The Pain Clinic is not only a treatment center but also a global academic hub. Over the past two decades, Daradia has:
- Trained more than 4,500 doctors worldwide in interventional pain techniques.
- Authored leading textbooks in pain medicine, referenced globally.
- Developed virtual simulators for fluoroscopy- and ultrasound-guided interventions.
- Conducted accredited online and offline fellowships in pain medicine.
By hosting ICRAPAIN 2025, Daradia reinforced its position as a pioneer of pain education and innovation in India and beyond.
Looking Ahead
The overwhelming success of ICRAPAIN 2025 highlights the growing demand for specialized education in pain medicine. With chronic pain being a global health priority, platforms like ICRAPAIN play a vital role in connecting physicians, researchers, and innovators across countries.
The organizing committee has already announced plans to expand collaborations and involve an even wider international faculty for the next edition of ICRAPAIN.
Final Thoughts
ICRAPAIN 2025 was more than a conference. It was a movement toward global collaboration in pain medicine. With participants from across continents, a diverse faculty, and an agenda that blended science, skills, and interaction, the event achieved its mission of advancing the art and science of pain care.
For Daradia, the journey continues—with the vision of being a center where research, education, and patient care unite to improve lives worldwide.
